ClinicalTrials.gg
CompletedNCT06628986postpartumUpdated Nov 3, 2026

MBSR and NLP, Postpartum Breastfeeding and Depression

An interventional study of MBSR and NLP in Breastfeeding, Exclusive, Fatigue and Sleep, sponsored by Aysegul Kilicli. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 19 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Aysegul Kilicli · Not applicable, Interventional, and Other

How we know

Updated Nov 3, 2026Now CompletedFirst site in Turkey (Türkiye)+7 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
19 Years to 35 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 274 studies in Breast Feeding with a site in Turkey — 68 open to participants now, 77 under way, none of them phase 3. Breast Feeding · Turkey.

Enrollment
93rd of 252
90 · median 80
Started
2024
with 51 others
No phase
251 of 274
65 open now
Registered
150th of 274
by date

Among the 274 studies in Breast Feeding with a site in Turkey, this one is the 93rd largest by enrollment of the 252 interventional ones that give a count, is one of 52 that started in 2024, is one of 251 with no phase, and was the 150th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

68 of the 274 studies in Breast Feeding with a site in Turkey are open now. Recruiting first, the newest first:

63 more — sign in →

All 68 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 19 Years to 35 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 274 studies in Breast Feeding with a site in Turkey, or all of them as a file.
02

Study summary

The postnatal period is a risky period in which mothers experience regressive and progressive changes and rapid biopsychosocial changes. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes that occur in this period.

Read the detailed description

The postnatal period is a risky period in which retrogressive and progressive changes and rapid biopsychosocial changes occur in mothers. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes occurring in this period. Studies have reported that the most common physical problems in the early postpartum period after caesarean section are pain in the incision area, difficulty in caring for the baby alone, activity intolerance, fatigue, insomnia, breastfeeding problems (such as nipple or lack of milk), mastitis and abdominal tension/gas. As important as it is to reduce postpartum symptoms after caesarean section, it is also important to support and maintain breastfeeding. However, postpartum symptoms such as pain, fatigue and negative effects of anaesthesia after caesarean section negatively affect the breastfeeding process and lead to a delay in the onset of lactation.

When the literature was examined, no study was found that examined the effects of mindfulness-based stress reduction programme and neurolinguistic programme on fatigue, sleep quality, lactation and depression in the postpartum long term.

03

Conditions studied

  • Breastfeeding, Exclusive
  • Fatigue
  • Sleep
  • Postpartum Depression

Keywords

  • breastfeeding
  • fatigue
  • sleep
  • postpartum depression
04

Who can participate

Ages eligible
19 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 19-35 years old
  • caesarean section
  • primiparous
  • breastfeeding women

Exclusion criteria

Exclusion Criteria:

  • women who refused to participate in the research.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Mindfulness-based stress reduction program

    MBSR; Mindfulness-based stress reduction program. 8 weeks of practice once a week for 20 minutes each. Mindfulness-based stress reduction practices will be carried out online. Mothers will actively participate.

    Behavioral: MBSR

  • Experimental
    Neurolinguistic programming

    NLP; Neurolinguistic programming 8 weeks of practice once a week for 20 minutes each. Neurolinguistic programming will be carried out online. Mothers will actively participate.

    Behavioral: NLP

  • Experimental
    control

    control; MBSR and NLP applications will not be performed. Mothers will be monitored online every week.

    Behavioral: control

Interventions

  • BehavioralMBSR

    20 minutes once a week for 8 weeks

    Also known as: MBSR mindfulness-based stress reduction program

  • BehavioralNLP

    NLP Neurolinguistic programming, 20 minutes once a week for 8 weeks

    Also known as: NLP Neurolinguistic programming

  • Behavioralcontrol

    control group, no practice,

    Also known as: control group

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale for Fatigue (VAS-F)

    Visual Analogue Scale for Fatigue (VAS-F), The most positive expression of the fatigue sub-dimension is 0 and the most negative expression is 10, the most negative expression of the energy sub-dimension is 0 and the most positive expression is 10.

    Time frame: before the first application

  2. Visual Analogue Scale for Fatigue (VAS-F)

    Visual Analogue Scale for Fatigue (VAS-F) The most positive expression of the fatigue sub-dimension is 0 and the most negative expression is 10, the most negative expression of the energy sub-dimension is 0 and the most positive expression is 10.

    Time frame: Week 4, following the intervention administered on that day

  3. Visual Analogue Scale for Fatigue (VAS-F)

    Visual Analogue Scale for Fatigue (VAS-F) The most positive expression of the fatigue sub-dimension is 0 and the most negative expression is 10, the most negative expression of the energy sub-dimension is 0 and the most positive expression is 10.

    Time frame: Week 8, following the final intervention

  4. Pittsburgh Sleep Quality Index (PSQI)

    Pittsburgh Sleep Quality Index (PSQI) Each item is evaluated as 0-3 points and the sum of the 7 subcomponents constitutes the PDQI score. The lowest score of the scale is 0 and the highest score is 21. A total PDQI score of ≤5 indicates good sleep and \>5 indicates poor sleep.

    Time frame: before the first application

  5. Pittsburgh Sleep Quality Index (PSQI)

    Pittsburgh Sleep Quality Index (PSQI) Each item is evaluated as 0-3 points and the sum of the 7 subcomponents constitutes the PDQI score. The lowest score of the scale is 0 and the highest score is 21. A total PDQI score of ≤5 indicates good sleep and \>5 indicates poor sleep.

    Time frame: week 4, following the intervention administered on that day

  6. Pittsburgh Sleep Quality Index (PSQI)

    Pittsburgh Sleep Quality Index (PSQI) Each item is evaluated as 0-3 points and the sum of the 7 subcomponents constitutes the PDQI score. The lowest score of the scale is 0 and the highest score is 21. A total PDQI score of ≤5 indicates good sleep and \>5 indicates poor sleep.

    Time frame: week 8, , following the final intervention

  7. Edinburgh Postpartum Depression Scale (EPDS)

    Edinburgh Postpartum Depression Scale (EPDS) The scale is a 4-point Likert-type scale consisting of 10 items. Responses consisting of four options are scored between 0 and 3. A minimum of 0 and a maximum of 30 points can be obtained from the scale. The cut-off point of the scale is 13 points and above for women and 10 points and above for men, and above this point indicates the presence of depression.

    Time frame: before the first application

  8. Edinburgh Postpartum Depression Scale (EPDS)

    Edinburgh Postpartum Depression Scale (EPDS) The scale is a 4-point Likert-type scale consisting of 10 items. Responses consisting of four options are scored between 0 and 3. A minimum of 0 and a maximum of 30 points can be obtained from the scale. The cut-off point of the scale is 13 points and above for women and 10 points and above for men, and above this point indicates the presence of depression.

    Time frame: week 4, following the intervention administered on that day

  9. Edinburgh Postpartum Depression Scale (EPDS)

    Edinburgh Postpartum Depression Scale (EPDS) The scale is a 4-point Likert-type scale consisting of 10 items. Responses consisting of four options are scored between 0 and 3. A minimum of 0 and a maximum of 30 points can be obtained from the scale. The cut-off point of the scale is 13 points and above for women and 10 points and above for men, and above this point indicates the presence of depression.

    Time frame: week 8, following the final intervention

  10. Breastfeeding Self-Efficacy Scale (BSES)

    Breastfeeding Self-Efficacy Scale (BSES) The scale consists of 14 items, five-point Likert type. The items of the scale are evaluated on a scale from '1=never sure' to 5=always sure'. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

    Time frame: before the first application

  11. Breastfeeding Self-Efficacy Scale (BSES)

    Breastfeeding Self-Efficacy Scale (BSES) The scale consists of 14 items, five-point Likert type. The items of the scale are evaluated on a scale from '1=never sure' to 5=always sure'. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

    Time frame: week 4, following the intervention administered on that day

  12. Breastfeeding Self-Efficacy Scale (BSES)

    Breastfeeding Self-Efficacy Scale (BSES) The scale consists of 14 items, five-point Likert type. The items of the scale are evaluated on a scale from '1=never sure' to 5=always sure'. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.

    Time frame: week 8, following the final intervention

  13. Exclusive breastfeeding status

    Exclusive breastfeeding status (yes or no)

    Time frame: before the first application

  14. Exclusive breastfeeding status

    Exclusive breastfeeding status (yes or no)

    Time frame: week 4, following the intervention administered on that day

  15. Exclusive breastfeeding status

    Exclusive breastfeeding status (yes or no)

    Time frame: week 8, following the final intervention

07

Study locations

1 site
  • Şanlıurfa training and research hospital
    Sanliurfa, Eyalet/Yerleşke 63000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — All

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: 8 October 2024 - 30 October 2025

Access criteria: 8 October 2024 - 30 October 2025

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Feb 2025, 3 months.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 3 months is below that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Oct 2025 → Feb 2025 and completion Oct 2025 → Feb 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 3, 2024
First posted
Oct 8, 2024
StartActual
Oct 8, 2024
Primary completionActual
Feb 1, 2025was Oct 2025
CompletionActual
Feb 1, 2025was Oct 2025
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 3, 2026
Sites
1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
Show site
  • Şanlıurfa training and research hospital · Sanliurfa, Turkey (Türkiye)
Show 1 removed
  • Şanlıurfa training and research hospital · Şanlıurfa, Turkey
Nov 3, 2026
Primary completion
Oct 30, 2025→Feb 1, 2025 (actual)
Nov 3, 2026
Study completion
Oct 30, 2025→Feb 1, 2025 (actual)
Nov 3, 2026
Primary outcomes
8 time frame changed, 3 added, 3 removed
What changed in the outcomes
  • AddedExclusive breastfeeding statusTime frame: before the first application
  • AddedExclusive breastfeeding statusTime frame: week 4, following the intervention administered on that day
  • AddedExclusive breastfeeding statusTime frame: week 8, following the final intervention
  • RemovedBristol Breastfeeding Assessment Tool (BBAT)Time frame: before the first application
  • RemovedBristol Breastfeeding Assessment Tool (BBAT)Time frame: week 4
  • RemovedBristol Breastfeeding Assessment Tool (BBAT)Time frame: week 8
  • Time frameVisual Analogue Scale for Fatigue (VAS-F)#2Week 4 → Week 4, following the intervention administered on that day
  • Time frameVisual Analogue Scale for Fatigue (VAS-F)#3Week 8 → Week 8, following the final intervention
  • Time framePittsburgh Sleep Quality Index (PSQI)#2week 4 → week 4, following the intervention administered on that day
  • Time framePittsburgh Sleep Quality Index (PSQI)#3week 8 → week 8, , following the final intervention
  • Time frameEdinburgh Postpartum Depression Scale (EPDS)#2week 4 → week 4, following the intervention administered on that day
  • Time frameEdinburgh Postpartum Depression Scale (EPDS)#3week 8 → week 8, following the final intervention
  • Time frameBreastfeeding Self-Efficacy Scale (BSES)#2week 4 → week 4, following the intervention administered on that day
  • Time frameBreastfeeding Self-Efficacy Scale (BSES)#3week 8 → week 8, following the final intervention
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Recruiting→Completed
    1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
    Show site
    • Şanlıurfa training and research hospital · Sanliurfa, Turkey (Türkiye)
    Show 1 removed
    • Şanlıurfa training and research hospital · Şanlıurfa, Turkey
    Primary completion Oct 30, 2025→Feb 1, 2025 (now actual)
    Study completion Oct 30, 2025→Feb 1, 2025 (now actual)
    Primary outcomes 8 time frame changed, 3 added, 3 removed
    What changed in the outcomes
    • AddedExclusive breastfeeding statusTime frame: before the first application
    • AddedExclusive breastfeeding statusTime frame: week 4, following the intervention administered on that day
    • AddedExclusive breastfeeding statusTime frame: week 8, following the final intervention
    • RemovedBristol Breastfeeding Assessment Tool (BBAT)Time frame: before the first application
    • RemovedBristol Breastfeeding Assessment Tool (BBAT)Time frame: week 4
    • RemovedBristol Breastfeeding Assessment Tool (BBAT)Time frame: week 8
    • Time frameVisual Analogue Scale for Fatigue (VAS-F)#2Week 4 → Week 4, following the intervention administered on that day
    • Time frameVisual Analogue Scale for Fatigue (VAS-F)#3Week 8 → Week 8, following the final intervention
    • Time framePittsburgh Sleep Quality Index (PSQI)#2week 4 → week 4, following the intervention administered on that day
    • Time framePittsburgh Sleep Quality Index (PSQI)#3week 8 → week 8, , following the final intervention
    • Time frameEdinburgh Postpartum Depression Scale (EPDS)#2week 4 → week 4, following the intervention administered on that day
    • Time frameEdinburgh Postpartum Depression Scale (EPDS)#3week 8 → week 8, following the final intervention
    • Time frameBreastfeeding Self-Efficacy Scale (BSES)#2week 4 → week 4, following the intervention administered on that day
    • Time frameBreastfeeding Self-Efficacy Scale (BSES)#3week 8 → week 8, following the final intervention
    + 4 other changes: verification date, design details, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06628986
Lead sponsor
Aysegul Kilicli
Responsible party
Aysegul Kilicli (Gaziantep University Health Sciences Institute, Department of Nursing PhD., University of Gaziantep) — Sponsor-investigator
First posted
Oct 8, 2024
Start date
Oct 8, 2024
Primary completion
Feb 1, 2025
Completion
Feb 1, 2025
Last update
Nov 3, 2026

Study contacts

AYŞEGÜL KILIÇLI, Dr.
study director · Muş Alparslan University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion